Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$25.57+1.34 (+5.53%)
Close on Nov 18, 2026Market cap $2.06BP/E 18.3Yield –
Veracyte operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Veracyte's operating cash flow for the twelve months ending Jun 30, 2026 was $178.38M, up 90.9% year over year. For fiscal 2025 it was $136.31M, up 81.5% from the year before. The highest annual figure on record is $136.31M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.31M | +81.5% |
| FY2024 | Dec 31, 2024 | $75.10M | +69.8% |
| FY2023 | Dec 31, 2023 | $44.22M | +486.9% |
| FY2022 | Dec 31, 2022 | $7.54M | – |
| FY2021 | Dec 31, 2021 | -$31.62M | – |
| FY2020 | Dec 31, 2020 | -$9.71M | – |
| FY2019 | Dec 31, 2019 | -$3.23M | – |
| FY2018 | Dec 31, 2018 | -$13.52M | – |
| FY2017 | Dec 31, 2017 | -$23.92M | – |
| FY2016 | Dec 31, 2016 | -$27.98M | – |
| FY2015 | Dec 31, 2015 | -$26.97M | – |
| FY2014 | Dec 31, 2014 | -$27.63M | – |
| FY2013 | Dec 31, 2013 | -$19.16M | – |
| FY2012 | Dec 31, 2012 | -$7.17M | – |
| FY2011 | Dec 31, 2011 | -$13.52M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $45.83M | +36.4% |
| Q1 FY2026 | Mar 31, 2026 | $35.22M | +556.8% |
| Q4 FY2025 | Dec 31, 2025 | $52.58M | +114.4% |
| Q3 FY2025 | Sep 30, 2025 | $44.76M | +49.4% |
| Q2 FY2025 | Jun 30, 2025 | $33.61M | +13.6% |
| Q1 FY2025 | Mar 31, 2025 | $5.36M | – |
| Q4 FY2024 | Dec 31, 2024 | $24.52M | +57.7% |
| Q3 FY2024 | Sep 30, 2024 | $29.96M | +111.4% |
| Q2 FY2024 | Jun 30, 2024 | $29.58M | +77.4% |
| Q1 FY2024 | Mar 31, 2024 | -$8.97M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.55M | +59.6% |
| Q3 FY2023 | Sep 30, 2023 | $14.17M | +101.7% |
| Q2 FY2023 | Jun 30, 2023 | $16.67M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.17M | – |
| Q4 FY2022 | Dec 31, 2022 | $9.74M | +15.4% |
| Q3 FY2022 | Sep 30, 2022 | $7.03M | – |
| Q2 FY2022 | Jun 30, 2022 | -$363.00K | -119.2% |
| Q1 FY2022 | Mar 31, 2022 | -$8.87M | – |
| Q4 FY2021 | Dec 31, 2021 | $8.45M | +273.6% |
| Q3 FY2021 | Sep 30, 2021 | -$1.39M | -179.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.89M | – |
| Q1 FY2021 | Mar 31, 2021 | -$40.56M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.26M | +26.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.42M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.30M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.56M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.46M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.01M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.23M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.78M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.41M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.82M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.10M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.91M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.23M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.44M | – |
See a number that looks wrong?